Tibolone: How does its mechanism of action translate into clinical effects

Maturitas

Volumn 48, Issue SUPPL. 1, 2004, Pages

  Kenemans, Peter ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE; TIBOLONE;

AROUSAL; BLEEDING; BLOOD FLOW; BONE; BRAIN; BREAST CARCINOMA; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; ENZYME REGULATION; FRACTURE; HORMONAL THERAPY; HUMAN; LIBIDO; MAMMOGRAPHY; MOOD; POSTMENOPAUSE; VAGINA;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; NORPREGNENES; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 4344658251     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.02.014     Document Type: Conference Paper

References (23)

1. Modelska K., Cummings S. Tibolone for postmenopausal women: systematic review of randomized trials. J. Clin. Endocrinol. Metab. 87:2002;6-23
2. Landgren M.B., Coelingh Bennink H.J.T., Helmond F.A., Engelen S. Dose-response analysis of effects of tibolone on climacteric symptoms. Br. J. Obstet. Gynaecol. 109:2002;1109-1114
3. Davis S. The effect of tibolone on mood and libido. Menopause. 9:2002;162-170
4. Dören M., Rübig A., Coelingh Bennink H.J.T., Holzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil. Steril. 75:2001;554-559
5. Kökçü A., Çetinkaya M.B., Yanik F., Alper T., Malatylioǧlu E. The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas. 36:2000;75-80
6. Castelo-Branco C., Vicente J., Figueras F., et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas. 34:2000;161-168
7. Punnonen R., Liukko P., Cortes-Prieto J., et al. Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomised women. Maturitas. 5:1984;281-286
8. Rymer J., Chapman M.G., Fogelman I. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas. 18:1994;127-133
9. Ederveen A.G.H., Kloosterboer H.J. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor. J. Bone Miner. Res. 16:2001;1651-1657
10. Gallagher J.C., Baylink D.J., Freeman R., McClung M. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies. J. Clin. Endocrinol. Metab. 86:2001;4717-4726
11. Berning B., Coelingh Bennink H.J.T., Fauser B.C.J.M. Tibolone and its effects on bone: a review. Climacteric. 4:2001;120-136
12. Roux C., Pelissier C., Fechtenbaum J., Loiseau-Peres S., Benhamou C. Randomized, double-masked, 2-year comparison of tibolone with 17β-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos. Int. 13:2002;241-248
13. Rymer J., Robinson J., Fogelman I. Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women. Climacteric. 5:2002;390-398
14. Hammar M., Christau S., Nathorst-Böös J., Rud T., Garre K. A double-blind randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br. J. Obstet. Gynaecol. 105:1998;904-911
15. Huber J., Palacios S., Berglund L., et al. The effect of tibolone compared with conjugated equine oestrogens continuously combined with medroxyprogesterone acetate on bleeding rates. Br. J. Obstet. Gynaecol. 109:2002;886-893
16. Völker W., Coelingh Bennink H.J.T., Helmond F.A. Effects of tibolone on the endometrium. Climacteric. 4:2001;203-208
17. Dören M., Rübig A., Coelingh Bennink H.J.T., Holzgreve W. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause. 6:1999;299-306
18. Lundström E., Christow A., Kersemaekers W., et al. Effects of tibolone and a continuous combined hormone replacement therapy on mammographic breast density. Am J. Obstet. Gynecol. 186:2002;717-722
19. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;62:419-27.
20. Crosignani PG, Dören M, Studd J, et al. Critical comments on the Million Women Study. Maturitas 2003;46:91-111.
21. Speroff L. The Million Women Study and breast cancer. Maturitas. 46:2003;1-6. [Editorial]
22. Chlebowski R.T., Hendrix S.L., Langer R.D. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA. 289:2003;3243-3253
23. Breast cancer and hormone-replacement therapy: the Million Women Study. Lancet 2003;362:1328-32 [Correspondence].